Virginia Senate Committee Advances Bill to Fund Psychedelic Studies for Veterans’ Mental Health – Ganjapreneur | Where to order Skittles Moonrock online
Learn where to buy marijuana online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
đ Click here to Visit our shop! đ
Mon / Jan 27th
Lawmakers in a Virginia Senate committee have advanced a bill funding clinical trials to investigate federally recognized âbreakthrough therapiesâ for veteransâ mental health issues, including psychedelic substances like MDMA and psilocybin.
Full story after the jump.
Lawmakers in the Virginia Senate Education and Health Committee last week advanced a bill to fund clinical trials investigating the benefits of federally recognized âbreakthrough therapiesâ for veteransâ mental health-related issues, which include psychedelic substances like psilocybin and MDMA, Marijuana Moment reports.
Introduced by state Sen. Ghazala F. Hashmi (D), SB 1101, or the Breakthrough Therapies for Veteran Suicide Prevention Act, does not name psychedelics specifically. Instead, the legislation carves out funding to study âbreakthrough therapiesâ as designated by the federal Food and Drug Administration (FDA), which has previously designated MDMA and psilocybin as breakthrough therapies for PTSD and depression, respectively. Those designations were assigned after studies found the Schedule I substances showed significant potential against otherwise treatment-resistant conditions, but federal law â which considers Schedule I substances to be void of medicinal benefits â hampered further research.
âWhat we are hoping to do with this legislation is to establish a dedicated fund for breakthrough therapies for veteran suicide prevention that would support clinical trials, patient access, as well as training for healthcare professionals.â â Hashmi, to members of the Senate Committee on Education and Healthâs Subcommittee on Health, via Marijuana Moment
During the federal lame-duck legislation session last year, U.S. Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) introduced a bipartisan proposal seeking to reschedule psychedelic substances with a âbreakthrough therapyâ designation from the FDA.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Ganjapreneur is made possible by our partners:
Latest Cannabis News
Massachusetts Cannabis Industry Sets $1.64B Annual Sales Record In 2024
Aurora Launches Germany-Based Medical Cannabis Brand
Nebraska Bills Aim to Help Implement Voter-Approved Medical Cannabis Program
Former Verano Executive Charged with Securities Fraud for Alleged Insider Trading
Class Action Lawsuit Attorneys Investigating Stiiizy Data Breach
Four Minnesota Shops Fined for Illegal Cannabis Sales
News by Market:
News by Topic:
- Stocks
- CBD
- Legalization
- Decriminalization
- Business
- Regulations
- Adult Use
- Medical Cannabis
- Social Equity
- Expungement
- Veterans
- Hemp Industry
- Events
- Politics
- Federal Policy
- Law Enforcement
- International
- Entrepreneurs
- Investing
- Licensing
- Banking
- Marketing
- Technology
- Celebrities
- Sports
- Popular Culture
- Normalization
- Extracts
- Edibles
- Lawsuits
Featured Business Profiles
From Our Partners
Trends in Cannabis and Hemp Prerolls: Premium Options and Custom Formulas
HempNova
Top Shelf DNA Genetics Strains for Indoor Growing Success
DNA Genetics
The 2024 Election and Cannabis Legalization: A Critical Turning Point
BGM CPA
Leave a Reply
Want to join the discussion?Feel free to contribute!